Prescribers advised to consider using other antibiotics in patients with heart disease.
Missing a dose of Acyclovir Tablets could cause a reactivation of a virus being treated.
Continued use of the device in AED mode after failure may lead to serious patient injury or death.
Design changes are intended to reduce the potential for leakage of patient fluids into the closed elevator channel and under the distal cap.
FDA has received seven reports of patients experiencing PE during, or soon after, a treatment.
Probability of a potentially sight threatening eye infection or impairment.
FDA is clarifying the current recommendations for screening, dosing, monitoring, and managing PBC patients with moderate to severe liver disease taking Ocaliva.
Parts of the chamber may split apart into layers, allowing water to overflow the chamber and back up into the patient breathing circuit, which could lead to serious adverse health consequences, including injury or death.
Reports of serious heart problems and deaths with much higher than recommended doses of loperamide. FDA working with manufacturers to use blister packs or other single dose packaging and to limit number of doses in a package.
UPDATED 01/30/2018. Primus voluntarily recalling all unexpired lots of Limbrel products to the patient (user/consumer) level.